Ontology highlight
ABSTRACT: Purpose
Myeloproliferative neoplasm (MPN) symptoms are troublesome to patients, and alleviation of this burden represents a paramount treatment objective in the development of MPN-directed therapies. We aimed to assess the utility of an abbreviated symptom score for the most pertinent and representative MPN symptoms for subsequent serial use in assessing response to therapy.Patients and methods
The Myeloproliferative Neoplasm Symptom Assessment Form total symptom score (MPN-SAF TSS) was calculated as the mean score for 10 items from two previously validated scoring systems. Questions focus on fatigue, concentration, early satiety, inactivity, night sweats, itching, bone pain, abdominal discomfort, weight loss, and fevers.Results
MPN-SAF TSS was calculable for 1,408
SUBMITTER: Emanuel RM
PROVIDER: S-EPMC4872304 | biostudies-literature | 2012 Nov
REPOSITORIES: biostudies-literature